Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy-Reference-Cited by-同舟云学术

Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy

Published:2016-09 Issue: Volume:99 Page:4-10
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Katsuya Yuki,Horinouchi Hidehito^ORCID,Asao Tetsuhiko,Kitahara Shinsuke,Goto Yasushi,Kanda Shintaro,Fujiwara Yutaka,Nokihara Hiroshi,Yamamoto Noboru,Watanabe Shun-ichi,Tsuta Koji,Ohe Yuichiro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Rare cancers are not so rare: the rare cancer burden in Europe;Gatta;Eur. J. Cancer,2011

2. A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L;Hirai;Ann. Oncol.,2015

3. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma;Lemma;J. Clin. Oncol.,2011

4. Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy;Okuma;J. Cancer Res. Clin. Oncol.,2015

5. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial;Thomas;Lancet Oncol.,2015

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer;Advanced Science;2024-09-05

2. Depiction of the Genetic Alterations and Molecular Landscapes of Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis;Cancers;2024-08-25

3. The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors;Clinical and Translational Oncology;2024-07-24

4. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy;Journal of Hematology & Oncology;2024-06-11

5. Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors;Exploration of Targeted Anti-tumor Therapy;2024-05-21